Next-Generation Peripheral Nerve Stimulation for Inflammatory Bowel Disease Treatment

A revolutionary, AI-driven peripheral nerve stimulation system for personalized treatment of inflammatory bowel disease, offering real-time adaptation, biomarker-based customization, and non-invasive wearable devices.

Current peripheral nerve stimulation treatments for inflammatory bowel disease are limited by their lack of personalization, invasive nature, and fixed stimulation protocols. The original patent addressed these limitations, but the next-generation system envisioned here tackles these issues more comprehensively, leveraging advancements in machine learning, wearable technology, and brain-computer interfaces to provide more effective and targeted therapy.

The proposed system consists of a wearable device with a flexible, conformable electrode array that transcutaneously stimulates the peripheral nerve. A machine learning algorithm integrated into the device adjusts stimulation parameters in real-time based on the patient's physiological response. Additionally, a neural network can predict an optimal stimulation protocol for the patient based on their symptoms, medical history, and genetic profile. The system can also incorporate a brain-computer interface to detect changes in the patient's brain activity and adjust the peripheral nerve stimulation accordingly. Furthermore, the system can identify specific inflammatory biomarkers and use a customized stimulation protocol tailored to the identified biomarkers to modulate the patient's immune response.

The novel aspects of this inventive concept include the integration of machine learning algorithms for real-time adaptation, the use of wearable devices with conformable electrode arrays, and the incorporation of brain-computer interfaces and biomarker-based customization. These advancements provide a significant improvement over existing peripheral nerve stimulation treatments, enabling more effective, personalized, and non-invasive therapy for inflammatory bowel disease.

Alternative embodiments of the system could include the use of different types of wearable devices, such as implantable or injectable devices, or the integration of other sensing modalities, such as electroencephalography or functional near-infrared spectroscopy. The system could also be adapted for treating other inflammatory diseases or conditions.

The next-generation peripheral nerve stimulation system has significant commercial potential in the treatment of inflammatory bowel disease, with a target market including pharmaceutical companies, medical device manufacturers, and healthcare providers. The system's personalized and non-invasive nature could also expand its market potential to include patients with other inflammatory diseases or conditions.